Literature DB >> 26046602

Dietary Intake and Weight Gain Among Adolescents on Depot Medroxyprogesterone Acetate.

Hannah L H Lange1, Martha A Belury2, Michelle Secic3, Alicia Thomas4, Andrea E Bonny5.   

Abstract

STUDY
OBJECTIVE: To examine the relationship between dietary intake and weight gain among adolescent females initiating depot medroxyprogesterone acetate (DMPA).
DESIGN: Prospective observational study.
SETTING: Two urban Adolescent Medicine clinics. PARTICIPANTS: 45 postmenarchal females, age 12 to 21, enrolled after self-selecting to initiate DMPA. INTERVENTION: Participants received 150 mg DMPA intramuscularly every 12 weeks. Height, weight, and 24-hour dietary recall were collected at baseline, 3, 6, and 12 months. MAIN OUTCOME MEASURE: Body mass index (BMI) over time calculated as weight (kg)/height (m(2)). Associations between dietary variables and BMI were evaluated with repeated measures analysis of variance modeling.
RESULTS: Mean chronological and gynecologic ages were 16.2 ± 1.5 and 4.2 ± 1.8 years, respectively. Mean BMI increased from 23.7 ± 5.3 to 25.3 ± 5.7 over 12 months. Average dietary intake included: 1781.4 ± 554.1 total kilocalories, 228.5 g ± 69.8 carbohydrates, 71.0 g ± 27.3 fat, and 61.0 g ± 20.2 protein. These diet measures were not associated with BMI over time. Dietary fiber, magnesium, and linoleic acid were inversely associated with increased BMI over time (P < .05)
CONCLUSION: We found no evidence that general measures of diet (energy, carbohydrates, fat, and protein), as assessed by 24-hour recall, were predictive of weight gain on DMPA. Several nutrients abundant in foods that benefit overall health were inversely associated with increased BMI over time, suggesting that diet quality, rather than quantity, is a more important predictor of DMPA-associated weight gain.
Copyright © 2015 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BMI; Depo Provera; adolescent health; contraception; nutrition

Mesh:

Substances:

Year:  2014        PMID: 26046602      PMCID: PMC4457940          DOI: 10.1016/j.jpag.2014.04.004

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  27 in total

Review 1.  Assessment of usual dietary intake in population studies of gene-diet interaction.

Authors:  Katherine L Tucker
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-10-13       Impact factor: 4.222

2.  Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL.

Authors:  Carolyn Westhoff; John K Jain; Ian Milsom; Amrit Ray
Journal:  Contraception       Date:  2007-02-23       Impact factor: 3.375

3.  Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.

Authors:  Z Harel; F M Biro; L M Kollar; J L Rauh
Journal:  J Adolesc Health       Date:  1996-08       Impact factor: 5.012

4.  Milk, dairy fat, dietary calcium, and weight gain: a longitudinal study of adolescents.

Authors:  Catherine S Berkey; Helaine R H Rockett; Walter C Willett; Graham A Colditz
Journal:  Arch Pediatr Adolesc Med       Date:  2005-06

5.  Physical findings and symptoms of depot medroxyprogesterone acetate use in adolescent females.

Authors:  S C Matson; K A Henderson; G J McGrath
Journal:  J Pediatr Adolesc Gynecol       Date:  1997-02       Impact factor: 1.814

6.  Weight change in adolescents who used hormonal contraception.

Authors:  W L Risser; L R Gefter; M S Barratt; J M Risser
Journal:  J Adolesc Health       Date:  1999-06       Impact factor: 5.012

7.  Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method.

Authors:  Andrea E Bonny; Julie Ziegler; Ray Harvey; Sara M Debanne; Michelle Secic; Barbara A Cromer
Journal:  Arch Pediatr Adolesc Med       Date:  2006-01

8.  Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.

Authors:  M Polaneczky; M Liblanc
Journal:  J Adolesc Health       Date:  1998-08       Impact factor: 5.012

9.  Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.

Authors:  M Polaneczky; M Guarnaccia; J Alon; J Wiley
Journal:  Fam Plann Perspect       Date:  1996 Jul-Aug

10.  Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use.

Authors:  Abbey B Berenson; Mahbubur Rahman
Journal:  Am J Obstet Gynecol       Date:  2009-03       Impact factor: 8.661

View more
  4 in total

1.  Recognition and treatment of mood dysregulation in adults with intellectual disability.

Authors:  Jason Noel
Journal:  Ment Health Clin       Date:  2018-11-01

2.  Changes in body weight and blood pressure among women using Depo-Provera injection in Northwest Ethiopia.

Authors:  Muluken Fekadie Zerihun; Tabarak Malik; Yohannes Mulu Ferede; Tesfahun Bekele; Yigizie Yeshaw
Journal:  BMC Res Notes       Date:  2019-08-15

Review 3.  Progestin-only contraceptives: effects on weight.

Authors:  Laureen M Lopez; Shanthi Ramesh; Mario Chen; Alison Edelman; Conrad Otterness; James Trussell; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2016-08-28

Review 4.  Dietary intake and eating behavior in depot medroxyprogesterone acetate users: a systematic review.

Authors:  P Silva; S Qadir; A Fernandes; L Bahamondes; J F Peipert
Journal:  Braz J Med Biol Res       Date:  2018-04-23       Impact factor: 2.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.